Back

Sex of donor cell and reprogramming conditions predict the extent and nature of imprinting defects in mouse iPSCs

Arez, M.; Eckersley-Maslin, M.; Klobucar, T.; von Gilsa Lopes, J.; Krueger, F. A.; Raposo, A.; Gendrel, A.-V.; Bernardes de Jesus, B.; Teixeira da Rocha, S.

2020-11-20 molecular biology
10.1101/2020.11.20.370973 bioRxiv
Show abstract

Reprogramming of somatic cells into induced Pluripotent Stem Cells (iPSCs) is a major leap towards personalized approaches to disease modelling and cell-replacement therapies. However, we still lack the ability to fully control the epigenetic status of iPSCs, which is a major hurdle for their downstream applications. A sensible indicator for epigenetic fidelity is genomic imprinting, a phenomenon dependent on DNA methylation, which is frequently perturbed in iPSCs by yet unidentified reasons. By using a secondary reprogramming system with murine hybrid donor cells, we conducted a thorough imprinting analysis using IMPLICON in multiple female and male iPSCs generated under different culture conditions. Our results show that imprinting defects are remarkably common in mouse iPSCs causing dysregulation of the typical monoallelic expression of imprinted genes. Interestingly, the nature of imprinting defects depends on the sex of the donor cell and their respective response to culture conditions. Under serum-free conditions, male iPSCs show global hypomethylation at imprinted regions, whereas in serum conditions show focal hypermethylation at specific loci. In contrast, female iPSCs always exhibit hypomethylation defects regardless of culture conditions. These imprinting defects are more severe than the global changes in DNA methylation, highlighting the sensitivity of imprinting loci to current iPSC generation protocols. Our results reveal clear predictors underlying different types of imprinting defects in mouse iPSCs. This knowledge is essential to devise novel reprogramming strategies aiming at generating epigenetically faithful iPSCs.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Stem Cell Reports
118 papers in training set
Top 0.1%
22.8%
2
Scientific Reports
3102 papers in training set
Top 9%
8.5%
3
Cell Reports Methods
141 papers in training set
Top 0.3%
7.3%
4
Epigenetics & Chromatin
42 papers in training set
Top 0.1%
6.9%
5
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 0.9%
4.9%
50% of probability mass above
6
Epigenetics
43 papers in training set
Top 0.1%
4.9%
7
iScience
1063 papers in training set
Top 3%
4.0%
8
Nature Communications
4913 papers in training set
Top 37%
4.0%
9
BMC Biology
248 papers in training set
Top 0.4%
2.8%
10
Nucleic Acids Research
1128 papers in training set
Top 7%
2.8%
11
Cells
232 papers in training set
Top 1%
2.1%
12
Molecular Omics
21 papers in training set
Top 0.1%
1.7%
13
Computational and Structural Biotechnology Journal
216 papers in training set
Top 4%
1.7%
14
Communications Biology
886 papers in training set
Top 11%
1.5%
15
International Journal of Molecular Sciences
453 papers in training set
Top 9%
1.5%
16
Cell Reports
1338 papers in training set
Top 27%
1.3%
17
eLife
5422 papers in training set
Top 55%
0.8%
18
PLOS Biology
408 papers in training set
Top 18%
0.8%
19
EMBO Reports
88 papers in training set
Top 0.5%
0.8%
20
Stem Cell Research & Therapy
30 papers in training set
Top 0.8%
0.8%
21
The EMBO Journal
267 papers in training set
Top 5%
0.8%
22
Life Science Alliance
263 papers in training set
Top 2%
0.7%
23
Genome Research
409 papers in training set
Top 5%
0.7%
24
BMC Genomics
328 papers in training set
Top 7%
0.7%
25
Frontiers in Genetics
197 papers in training set
Top 11%
0.7%
26
Science Advances
1098 papers in training set
Top 32%
0.7%
27
PLOS Computational Biology
1633 papers in training set
Top 27%
0.7%
28
Molecular Therapy
71 papers in training set
Top 3%
0.7%
29
Methods
29 papers in training set
Top 0.9%
0.5%
30
Biomaterials Advances
20 papers in training set
Top 0.8%
0.5%